NASDAQ:OZEM Roundhill GLP-1 & Weight Loss ETF (OZEM) Price, Holdings, & News $26.55 -0.58 (-2.14%) As of 03:56 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock About Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get OZEM alerts:Sign Up Key Stats Today's Range$26.55▼$27.0950-Day Range$20.67▼$27.6952-Week Range$20.01▼$29.21Volume24,205 shsAverage Volume13,077 shsMarket Capitalization$38.50 millionAssets Under Management$37.99 millionDividend Yield0.19%Net Expense Ratio0.59%Aggregate RatingModerate Buy ETF OverviewThe Roundhill GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management. OZEM was launched on May 21, 2024 and is issued by Roundhill.Read More… Roundhill GLP-1 & Weight Loss ETF ExpensesTypeOZEMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.59%0.57%0.57%0.54%0.54%Other Expenses0.00%0.55%0.48%0.42%0.51%Total Expense0.59%0.73%0.72%0.69%0.71%Fee Waiver0.00%-0.69%-0.48%-0.29%-0.54%Net Expense0.59%0.60%0.63%0.62%0.60% Receive OZEM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roundhill GLP-1 & Weight Loss ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address OZEM ETF News HeadlinesHow to avoid nausea on Ozempic and GLP-1 medicationsMarch 17, 2025 | msn.comEmployers face pressure to add coverage of Ozempic, other weight-loss drugsMarch 12, 2025 | bizjournals.comNvidia’s Huang: AI is going to need 100x more powerNvidia CEO Jensen Huang didn't mince words. After Nvidia's latest earnings call, Huang said AI now requires "100 times more" power. Chip giant AMD's Chief Executive Lisa Su agrees. She declared that the need for more power is already "orders of magnitude higher" than just last year.June 16, 2025 | Weiss Ratings (Ad)Here’s why Ozempic maker’s new weight-loss drug isn’t good enough for investorsMarch 11, 2025 | msn.comNaturally occurring molecule rivals Ozempic in weight loss, sidesteps side effectsMarch 7, 2025 | msn.comMore yogurt and nuts, less alcohol and snack foods: How GLP-1 medications like Ozempic are influencing people’s food spending habitsMarch 5, 2025 | yahoo.comSee More Headlines OZEM ETF - Frequently Asked Questions How have OZEM shares performed this year? Roundhill GLP-1 & Weight Loss ETF's stock was trading at $24.36 on January 1st, 2025. Since then, OZEM shares have increased by 9.0% and is now trading at $26.55. View the best growth stocks for 2025 here. Who are Roundhill GLP-1 & Weight Loss ETF's major shareholders? Top institutional shareholders of Roundhill GLP-1 & Weight Loss ETF include National Bank of Canada FI (5.24%), Jane Street Group LLC (5.07%), OLD Mission Capital LLC (3.72%) and Flow Traders U.S. LLC (1.43%). How do I buy shares of Roundhill GLP-1 & Weight Loss ETF? Shares of OZEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Roundhill GLP-1 & Weight Loss ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Roundhill GLP-1 & Weight Loss ETF investors own include NVIDIA (NVDA), ARM (ARM), Berkshire Hathaway (BRK.B), Chipotle Mexican Grill (CMG), Coinbase Global (COIN), Femasys (FEMY) and Super Micro Computer (SMCI). Fund Details IssuerRoundhill Investments Fund NameRoundhill GLP-1 & Weight Loss ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:OZEM Inception Date5/21/2024 Fund ManagerWill Hershey, Tim Maloney, Dave Mazza, Drew Walsh Previous SymbolNASDAQ:OZEM WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings54 Fund Statistics Assets Under Management$37.99 million Average Daily Volume$0.00 Discount/Premium-0.04% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRoundhill Financial, Inc. CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerOld Mission Options OptionableOptionable Options Volume20 Put Options20 Call Options1 Short Interest2,600 shs Miscellaneous Outstanding Shares1,450,000BetaN/A These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report Top 10 OZEM HoldingsNovo Nordisk A/S (NYSE:NVO)Holding Weight: 20.89%Eli Lilly and Company (NYSE:LLY)Holding Weight: 13.41%Zealand Pharma A/SHolding Weight: 5.24%Roche Holding AGHolding Weight: 5.03%Innovent Biologics, Inc.Holding Weight: 4.41%Viking Therapeutics (NASDAQ:VKTX)Holding Weight: 3.99%Chugai Pharmaceutical Co., Ltd.Holding Weight: 3.76%Metsera (NASDAQ:MTSR)Holding Weight: 3.71%Hanmi Pharm. Co., Ltd.Holding Weight: 3.67%Altimmune (NASDAQ:ALT)Holding Weight: 3.57%Full Holdings DetailsOZEM Sector ExposureOZEM Industry Exposure This page (NASDAQ:OZEM) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredSomething Big Is Coming...Man who predicted Lehman Crash Warns "Get OUT of Cash" He predicted the 2008 crisis and recommended shortin...Stansberry Research | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. Chinese AI chatbot DeepSeek turned the tech world on its hea...Weiss Ratings | SponsoredSocial Security Boss drops huge Elon announcement…Elon's Successor? Elon Musk and President Trump's new feud is all over the news... but before he left Washi...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
